mass spectrometry comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
The molecule is a short, linear, hydrophilic peptide that dissolves readily in water or aqueous buffer. Its principal chemical liabilities are hydrolytic rather than oxidative, since it contains no cysteine, methionine, or tryptophan residues. The aspartate–glycine step is a recognised site for aspartimide formation under mildly acidic or basic conditions, generating isoaspartate and succinimide-related products over time. Desiccated lyophilised powder held at −20 °C is comparatively stable, whereas dilute solutions degrade faster and are best frozen as single-use aliquots rather than thawed repeatedly.
No pharmacopoeial monograph exists for this peptide, so quality rests on the supplier's internal specifications and on whatever independent testing a purchaser arranges. Certificates of analysis differ widely in which tests they report and in the limits applied. The counter-ion introduced during purification, commonly acetate or trifluoroacetate, changes the net peptide content of a given mass of powder, so two samples of equal weight may not contain equal amounts of the active sequence. Third-party laboratories can verify purity, identity, residual solvents, and counter-ion content for a fee, which makes documentation more informative than labelling.
Verification of a sample usually begins with reversed-phase high-performance liquid chromatography, which resolves the peptide from truncated sequences and other impurities and expresses purity as a percentage of total peak area. Mass spectrometry by electrospray ionisation or matrix-assisted laser desorption supplies an independent check, because the measured mass can be compared against the theoretical value for AEDG. Amino acid analysis or tandem mass spectrometry sequencing can confirm residue order. Each of these methods answers a different question: a purity figure does not establish identity, and an identity match does not establish how much of the material is intact peptide.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | RP-HPLC | Reported as percent area, often ≥95% |
| Identity confirmation | Mass spectrometry | Observed mass compared with ~390 Da |
| Typical storage temperature | -20 °C or below | Lyophilized powder, desiccated |
| Reconstitution solvent | Sterile water or buffer | Acidic residues aid dissolution |
| Common synonyms | AEDG; epithalon | Spelling varies in literature |
Short peptides such as AEDG are normally supplied as a freeze-dried solid and are kept dry, cold, and shielded from light. Holding at minus twenty degrees Celsius is common for the long term, while a refrigerator suffices for brief periods before use. The material takes up moisture to some degree, so containers should stay sealed and be allowed to reach room temperature before opening, which limits condensation on the contents. Repeated warming and cooling of a single container is discouraged because it admits water and can lower the amount of intact peptide.
Dissolution is usually performed in water or a suitable aqueous buffer, and the resulting liquid is divided into single-use portions before freezing. Freeze-thaw cycling is a recognised source of loss for short peptides, since each cycle can encourage aggregation or adsorption onto container walls. Working solutions are generally kept cold and used within a short window, although published stability data specific to epitalon are thin. Containers should be marked with concentration and date, and solutions examined for cloudiness before use.
Identity is normally established by reversed-phase high-performance liquid chromatography combined with mass spectrometry, a pairing that separates components and confirms molecular mass at once. Purity is quoted as a percentage from the chromatogram, and figures above ninety-five percent are a frequent commercial specification. Amino acid analysis or sequencing supplies further confirmation when required. Because many short peptides behave similarly under chromatography, retention time alone does not establish sequence; the mass measurement is what separates one tetrapeptide from another, and certificates should report both.
== Bibliography (selection) == Langer, Ellen J. (1989). Mindfulness. Reading, MA: Addison Wesley. ISBN 978-0-201-52341-6. Langer, Ellen J. (1997). The Power of Mindful Learning. Reading, MA: Addison-Wesley. ISBN 978-0-201-33991-8. Langer, Ellen J. (2005). On Becoming an Artist. New York: Ballantine Books. ISBN 978-0-345-45629-8. Langer, Ellen J. (2009). Counter clockwise: mindful health and the power of possibility. New York: Ballantine Books. ISBN 978-0-345-50204-9. Langer, Ellen J. (2023). The Mindful Body: Thinking Our Way to Chronic Health. New York: Ballantine Books. ISBN 978-0-593-49794-4.
== See also == Timeline of computing 2020–present Pandemic prevention § Surveillance and mapping COVID-19 surveillance Teamwork Open-source software development Citizen science § COVID-19 pandemic Information management COVID-19 pandemic#Information dissemination Open-source ventilator Bioinformatics Impact of the COVID-19 pandemic on science and technology#Computing and machine learning research and citizen science Public health mitigation of COVID-19 § Information technology Technology policy
Indigenous Americans mastered smelting, soldering, annealing, electroplating, sintering, alloying, low-wax casting, and many other metallurgical techniques independent of any Old World influences. The Moche were skilled in hammering and shaping gold, silver, copper, and bronze into intricate ornamental objects and chisels, while the later Incas developed more utilitarian objects using these metals and alloys. Metallurgical techniques later diffused from the Andean region of South America to Colombia and then later to Mesoamerica, where local artists and metallurgists developed even more unique techniques using a wide range of material, including alloys of copper-silver, copper-arsenic, copper-tin and copper-arsenic-tin. Moccasins – highly comfortable shoes used by indigenous Americans to travel vast distances. These shoes were often made of leather and were highly comfortable to wear. In addition, the moccasins could withstand the rugged terrain over which Native Americans traversed.
A few psychiatrists (including Sakel) claimed success rates for insulin coma therapy of over 80% in the treatment of schizophrenia. A few others argued that it merely accelerated remission in those patients who were undergoing remission anyway. The consensus at the time was somewhere in between, claiming a success rate of about 50% in patients who had been ill for less than a year (about double the spontaneous remission rate) with no influence on relapse. Sakel suggested the therapy worked by "causing an intensification of the tonus of the parasympathetic end of the autonomic nervous system, by blockading the nerve cell, and by strengthening the anabolic force which induces the restoration of the normal function of the nerve cell and the recovery of the patient." The shock therapies in general had developed on the erroneous premise that epilepsy and schizophrenia rarely occurred in the same patient. The premise was supported by neuropathologic studies that found a dearth of glia in the brains of schizophrenic patients and a surplus of glia in epileptic brains. These observations led the Hungarian neuropsychiatrist Ladislas Meduna to induce seizures in schizophrenic patients with injections of camphor, soon replaced by pentylenetetrazol (Metrazole). Another theory was that patients were somehow "jolted" out of their mental illness. The hypoglycemia (pathologically low glucose levels) that resulted from insulin coma therapy made patients extremely restless, sweaty, and liable to further convulsions and "after-shocks".
Sources: en.wikipedia.org
=== Parkinson's disease === Apomorphine is used for the management of motor fluctuations in Parkinson's disease, particularly for the treatment of "off" episodes. "Off" episodes are periods during which motor symptoms such as rigidity, bradykinesia, or reduced mobility reemerge as the effects of dopaminergic medications wear off. Apomorphine can provide rapid improvement in motor symptoms. Apomorphine is administered in multiple pharmaceutical formulations. Intermittent subcutaneous injection is used as an acute treatment and has been shown to terminate "off" episodes in individuals with motor fluctuations not adequately controlled with oral therapy. Sublingual apomorphine film has been reported in a recent narrative review to produce rapid off‑to‑on conversion and clinically meaningful short‑term improvements in motor scores when used as an on‑demand treatment for off episodes in Parkinson's disease, but an MDS evidence‑based review judged the randomized‑trial data insufficient to conclude that intermittent apomorphine formulations (including sublingual film) provide sustained benefits in disability or quality of life over 12‑week treatment periods. Continuous subcutaneous infusion of apomorphine using a wearable infusion device is also prescribed for individuals with motor fluctuations. Continuous infusion treatment is used in patients whose symptoms are not adequately controlled with oral or transdermal therapies and has been shown to reduce daily "off" time.
=== Transcriptional activities === The shorter p110 CUX1 isoform stably interacts with DNA and can function as transcriptional repressor or activator depending on promoter context. Transcription and cell-based assays demonstrated a role for p110 CUX1 in stimulating cell cycle progression and cell proliferation, strengthening of the spindle assembly checkpoint, ensuring an efficient DNA damage response, promoting cell migration and invasion, and increasing resistance to apoptotic signals. Of note, the p200 CUX1 protein was inactive in all these transcriptional and cell-based assays. p110 CUX1 has been demonstrated to bind the protective allele of FTO single nucleotide polymorphisms (SNPs) rs8050136 or rs1421085 highly associated with human obesity, and promote the expression of RPGRIP1L. RPGRIP1L hypomorphism in mice results in obesity, suggesting an important role of CUX1 in body weight regulation.
dimer An oligomer consisting of two monomers joined by chemical bonds that may variably be strong or weak, covalent or intermolecular. A homodimer consists of two identical molecules; a heterodimer consists of two different molecules.
Sources: en.wikipedia.org
=== Mixed with polyketides === Due to the similarity with polyketide synthases (PKS), many secondary metabolites are, in fact, fusions of NRPs and polyketides. In essence, this occurs when PK modules follow NRP modules, and vice versa. This is possible because the carrier domains (PCP/ACP) are quite similar between each other and they use a similar "chain-flipping" action to access the growing substrate. Although there is high degree of similarity between the Carrier (PCP/ACP) domains of both types of synthetases, the mechanism of condensation is different from a chemical standpoint:
However, there has been criticism where it favors the idea for lips, with the 2017 analytical study proposing that tyrannosaurids had large, flat scales on their snouts instead of lips, as modern crocodiles do. But crocodiles possess rather cracked keratinized skin, not flat scales; by observing the hummocky rugosity of tyrannosaurids, and comparing it to extant lizards, researchers have found that tyrannosaurids had squamose scales rather than a crocodillian-like skin. In 2023, Cullen and colleagues supported the idea that theropods like tyrannosaurids had lips based on anatomical patterns, such as those of the foramina on their face and jaws, more similar to those of modern squamates such as monitor lizards or marine iguanas than those of modern crocodilians like alligators. Comparison of the teeth of Daspletosaurus and American alligators shows that the enamel of tyrannosaurids had no significant wear and that the teeth of modern crocodilians were eroded on the labial side and were substantially worn. This suggests that it is likely that theropod teeth were kept wet by lips. On the basis of the relationship between hydration and wear resistance, the authors argued that it is unlikely that the teeth of theropods, including tyrannosaurids, would have remained unworn when exposed for a long time, because it would have been hard to maintain hydration.
== Description == Boea hygroscopica is an herbaceous or woody plant growing no taller than 1 m (3 ft 3 in). The flowers are 20–22 millimetres (0.8–0.9 in) in diameter and the peduncles (flower stems) are 85–90 millimetres (3.3–3.5 in) long. There are 5 petals and they are dimorphic, with 2 larger ones about 10 by 8 mm (0.4 by 0.3 in) and 3 smaller ones about 10 by 5 mm (0.4 by 0.2 in).
Sources: en.wikipedia.org
Identity is normally confirmed by mass spectrometry, which checks the measured mass against the expected value near 390 daltons. Reverse-phase high-performance liquid chromatography is used alongside it to assess purity. Amino acid analysis can provide additional composition data.
The powder is generally kept refrigerated or frozen, protected from light and moisture. Vials should reach room temperature before opening to prevent condensation. Reconstituted solutions are usually stored cold and used within a limited window because dilute solutions can degrade or support microbial growth.
Epitalon is not an approved drug in major Western regulatory jurisdictions. Its legal status differs between countries, and it is often distributed as a research chemical. This means product documentation and purity vary considerably between suppliers.
Mass spectrometry provides the identity check, because the observed mass is compared with the theoretical mass of the AEDG sequence. Chromatography separates and quantifies impurities but does not by itself prove which peptide is present. The two techniques are normally used together.